Lv2
199 积分 2025-12-16 加入
Evaluation of the Application Methods of Topical Steroids and Antimycotics for Seborrheic Dermatitis :
3天前
求助中
Poster Presentations
3天前
已完结
33460 Roflumilast foam 0.3% treatment of seborrheic dermatitis is effective and safe and improves patient quality of life: Results from a phase 2 study
3天前
已完结
388 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: assessment of pruritus
3天前
待确认
42835 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: Assessment of Pruritus
3天前
已完结
PCR204 Impact of Roflumilast Foam 0.3% on Patient-Reported Quality of Life in Seborrheic Dermatitis: An Analysis of Stratum Data for Patients Unresponsive or Intolerant to Topical Corticosteroids
3天前
已完结
IL-12/23-targeting in seborrheic dermatitis patients leads to long-lasting response
3天前
已完结
504 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis
3天前
待确认
53894 Roflumilast foam 0.3% once daily in patients with seborrheic dermatitis: Improvement in patient reported outcomes and pruritus from a phase 3 trial (STRATUM)
3天前
已完结
640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis
3天前
已完结